EMPLDM Met Tablet 5/1000 mg
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
MFDS item code 202201664 · Approved 2022.04.22
Improves blood glucose control in adults with type 2 diabetes mellitus
This medication is used to assist adults with type 2 diabetes in controlling their blood sugar levels, in conjunction with dietary and exercise therapy. It is especially effective for patients whose blood sugar is not adequately controlled, as the combined effects of empagliflozin and metformin contribute to effectively lowering blood sugar. Furthermore, for patients with cardiovascular diseases, there are precautions regarding the risk of cardiovascular events, so it should be used under the guidance of a healthcare professional. Overall, this medication plays a crucial role in improving blood sugar management in patients with type 2 diabetes.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient’s current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who are unable to achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose when taking this medicine is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and the patient’s current metformin dose. If empagliflozin 10 mg (total daily dose) is well tolerated and additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching to this medicine from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin should receive the same doses of empagliflozin and metformin as before. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see Precautions for Use, 4. Adverse Reactions and 6. Interactions). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Special populations Patients with renal impairment No dose adjustment is necessary for patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with the individual components, empagliflozin and metformin. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see Precautions for Use, 3. Patients Requiring Caution, item 1)). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine must be discontinued immediately (see Precautions for Use, 2. Patients Who Must Not Take This Medicine, item 2)). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication helps to regulate blood sugar. However, it is important to adhere to various precautions when taking this medication. Firstly, this medication may cause a rare side effect known as severe lactic acidosis, which can be life-threatening, so caution is warranted. Lactic acidosis is a condition that occurs when there is an excessive accumulation of lactic acid in the body, with symptoms including malaise, muscle aches, difficulty breathing, weakness, and abdominal pain. In addition, when taken with insulin or sulfonylurea, there is a risk of hypoglycemia, so it’s important to be aware of hypoglycemic symptoms. Symptoms of hypoglycemia include dizziness, cold sweat, trembling, and headache. Patients with moderate to severe renal dysfunction, acute kidney problems, severe infections, unstable heart function, type 1 diabetes, and pregnant or breastfeeding women should not use this medication. This medication can affect kidney function, so regular kidney function tests should be conducted before and during treatment. Extreme caution is also advised during episodes of dehydration or severe vomiting and diarrhea, as these can increase the risk of worsening kidney function. The use of iodinated contrast media before and after certain examinations requires a temporary discontinuation of this medication, and it should be resumed only after confirming normal kidney function. During the course of this medication, urinary tract or genital infections may occur; hence, any signs of infection must be reported to healthcare providers immediately. Gastrointestinal disturbances (such as diarrhea, nausea, vomiting), skin rash, itching, increased urination, fluid loss, hypoglycemia, vitamin B12 deficiency, and other adverse reactions may occur; any abnormal symptoms should be discussed with a healthcare professional. Consumption of alcohol may increase the risk of side effects associated with this medication; therefore, alcohol should be avoided during use. Elderly patients or those with impaired kidney function should be especially cautious and require dose adjustments and regular monitoring. Pregnant women or those who may become pregnant, as well as breastfeeding women, should not take this medication, and alternative treatments should be considered if necessary. In case of overdose, serious side effects may occur, so the prescribed dose must be strictly adhered to, and immediate medical attention should be sought in the event of an overdose. It is essential to regularly monitor blood sugar and kidney function during the course of this medication. Additionally, consult a healthcare professional regarding possible interactions with other drugs when taking this medication.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a sealed container to avoid exposure to air or moisture. The recommended storage temperature is at room temperature between 1°C and 30°C.
Biconvex oval film-coated tablet that is yellow with a brownish tint
10 tablets/box [10 tablets/PTP × 1], 60 tablets/box [10 tablets/PTP × 6], 30 tablets/bottle, 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Dongwha Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.